Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 21;13(2):98.
doi: 10.3390/vaccines13020098.

Racial and Ethnic Disparities in Human Papillomavirus Vaccination Among US-Born and Foreign-Born Adults Aged 18 to 26 Years in the United States

Affiliations

Racial and Ethnic Disparities in Human Papillomavirus Vaccination Among US-Born and Foreign-Born Adults Aged 18 to 26 Years in the United States

Itunu Sokale et al. Vaccines (Basel). .

Abstract

Background/objectives: Human papillomavirus (HPV) is linked to multiple cancers that can be prevented through vaccination. While the optimal age for vaccination is in childhood and adolescence, vaccination recommendations include adults through age 26 who missed childhood/adolescent vaccination. There are limited data about disparities among adults eligible for catch-up HPV vaccination. We conducted a comprehensive examination of HPV vaccination among US young adults, disaggregating the group by race/ethnicity and nativity status to identify subgroups that may require additional interventions.

Methods: We analyzed 2019 and 2022 data of individuals aged 18-26 years from the National Health Interview Survey. Generalized linear models using Poisson regression with log link were used to examine the receipt of 1+ dose of HPV vaccine, race/ethnicity, and nativity (i.e., US- versus foreign-born) status.

Results: The overall receipt of 1+ doses of HPV vaccine was 47.5%. The vaccination rate among the US-born group was 49.7% versus 31.9% among the foreign-born group with an adjusted prevalence ratio (APR) of 0.72; (95% CI, 0.62-0.82). Foreign-born non-Hispanic (NH) Black individuals (APR 0.31; 95% CI, 0.13-0.70) were less likely to be vaccinated against HPV than foreign-born NH White individuals, while US-born NH Asians (APR 1.27; 95% CI, 1.09-1.48) had a higher prevalence of the vaccination than the US-born NH White group. Additionally, foreign-born NH Asian (APR 0.60; 95% CI, 0.46-0.77), NH Black (APR 0.27; 95% CI, 0.12-0.61), and Hispanic (APR 0.76; 95% CI, 0.60-0.97) populations were less likely to be vaccinated than their respective US-born counterparts. Conclusion: Profound HPV vaccination inequalities exist among US young adults with particularly low vaccine coverage among racially and ethnically minoritized immigrant populations.

Keywords: HPV vaccination; foreign-born populations; human papillomavirus; racial and ethnic minority populations; vaccine inequalities; young adults.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Weighted HPV vaccination rates among US young adults aged 18–26 years, by nativity and race/ethnicity. Abbreviations: HPV, human papillomavirus; NH, non-Hispanic. Race/ethnicity groups are mutually exclusive, and Hispanic/Latinos could be of any race. Other includes American Indian/Alaska Native, Asian, Native Hawaiian/Pacific Islander, and multiple races. Respondents were considered foreign-born if they reported that they were not born in the United States or any of its territories.
Figure 2
Figure 2
Weighted HPV vaccination rates among racial–ethnic groups of US young adults aged 18–26 years stratified by nativity. Abbreviations: HPV, human papillomavirus; NH, non-Hispanic; Race/ethnicity groups are mutually exclusive, and Hispanic/Latinos could be of any race; Other includes American Indian/Alaska Native; Asian, Native Hawaiian/Pacific Islander, and multiple races. Respondents were considered foreign-born if they reported that they were not born in the United States or any of its territories.

Similar articles

Cited by

References

    1. Chesson H.W., Dunne E.F., Hariri S., Markowitz L.E. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex. Transm. Dis. 2014;41:660–664. doi: 10.1097/OLQ.0000000000000193. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention HPV Vaccination. [(accessed on 21 October 2024)]; Available online: https://www.cdc.gov/hpv/vaccines/index.html#:~:text=The%20vaccine%20is%2....
    1. International Agency for Research on Cancer Human Papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 90. [(accessed on 2 August 2024)]. Available online: https://publications.iarc.fr/108.
    1. NIH National Institute on Deafness and Other Communication Disorder Recurrent Respiratory Papillomatosis or Laryngeal Papillomatosis. [(accessed on 2 December 2024)]; Available online: https://www.nidcd.nih.gov/health/recurrent-respiratory-papillomatosis.
    1. American Cancer Society Prevent 6 Cancers with the HPV Vaccine. [(accessed on 21 October 2024)]. Available online: https://www.cancer.org/cancer/risk-prevention/hpv/hpv-vaccine.html.

LinkOut - more resources